Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Already a member? Log in here
Emerging Tests-dtet
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Already a member? Log in here
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Already a member? Log in here
Expanded Carrier Screening IDs Rare Variants in Diverse Populations
From – Diagnostic Testing & Emerging Technologies
Expanded next-generation sequencing-based carrier screening improves detection of rare and novel pathogenic variants even in…
Already a member? Log in here
Genetic Risk Score Could Improve Diagnosis of Atrial Fibrillation
From – Diagnostic Testing & Emerging Technologies
A genetic risk score (GRS) may identify patients at highest risk for developing atrial fibrillation (AF), according to a study published…
Already a member? Log in here
Fecal Profiling Could Personalize Diets with Irritable Bowel
...
Already a member? Log in here
Artificial Intelligence Merges Histology, Genomics to Predict Survival
...
Already a member? Log in here
SIDs Results From Genetic Heart Disease Less Than Previously Thought
From – Diagnostic Testing & Emerging Technologies
The vast majority of sudden infant death syndrome (SIDS) cases are not the result of genetic heart diseases (GHDs) or a single genetic cause…
Already a member? Log in here
Researchers Develop First Multiplex Test for Tick-Borne Disease Detection
From – Diagnostic Testing & Emerging Technologies
Researchers have developed the first multiplex array for diagnosis of tickborne diseases, according to a study published online…
Already a member? Log in here
Evidence for Liquid Biopsy Lacking, Expert Panel Finds
From – Diagnostic Testing & Emerging Technologies
There is not enough evidence, currently, to support the routine adoption of liquid biopsy tests for any of its promising clinical uses, according to a joint review published…
Already a member? Log in here
Dermatology Conference Highlights Gene Expression Tests for Skin Cancer
From – Diagnostic Testing & Emerging Technologies
Several companies presented findings at the American Academy of Dermatology’s annual meeting (Feb. 16-18, San Diego) indicating that…
Already a member? Log in here
Genotype-Matched Diets Don’t Aid Weight Loss
...
Already a member? Log in here